Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
Okuno M, Hatano E, Toda R, Nishino H, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokuka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S.
Okuno M, et al. Among authors: yazawa t.
J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):496-509. doi: 10.1002/jhbp.747. Epub 2020 Jun 9.
J Hepatobiliary Pancreat Sci. 2020.
PMID: 32362018
Free article.
Clinical Trial.